Moderna is asking Health Canada to approve its COVID-19 vaccine for use in adolescents aged 12 and older, following a study that showed doses were “highly effective” at preventing infection in that age group.
The submission was made on Monday morning and is currently awaiting Health Canada’s go-ahead.
“We are pleased to announce that we have submitted for authorization of our COVID-19 vaccine for use in adolescents with Health Canada,” said Stéphane Bancel, chief executive officer of Moderna.
“We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents.”
The submission comes just over a month after Health Canada approved the Pfizer COVID-19 vaccine, which uses the same mRNA technology as the Moderna vaccine, for adolescents.
Moderna studied the vaccine’s effects on nearly 2,500 adolescents and found that it was 100 per cent effective at preventing symptomatic COVID-19. It was also found to be 93 per cent effective at preventing milder COVID-19, the company said.
More to come
© 2021 Global News, a division of Corus Entertainment Inc.